Medical University of Gdańsk, Faculty of Pharmacy, Department of Physical Chemistry, 80-416 Gdańsk, Al. Gen. Hallera 107, Poland.
J Pharm Biomed Anal. 2012 Jan 25;58:200-7. doi: 10.1016/j.jpba.2011.09.003. Epub 2011 Sep 10.
The pharmaceutical industry is one of the more important sectors for the use of polydimethylsiloxanes (PDMS), which belong to the organosilicon polymers. In drugs for internal use, they are used as an active pharmaceutical ingredient (API) called dimeticone or simeticone. Due to their specific chemical nature, PDMS can have different degrees of polymerization, which determine the molecular weight and viscosity. The Pharmacopoeial monographs for dimeticone and simeticone, only give the permitted polymerization and viscosity range. It is, however, essential to know also the degree of polymerization or the specific molecular weight of PDMS that are present in pharmaceutical formulations. In the literature there is information about the impact of particle size, and thus molecular weight, on the toxicity, absorption and migration in living organisms. This study focused on the use of a developed method - the exclusion chromatography with evaporative light scattering detector (SEC-ELSD) - for identification and determination of dimeticone and simeticone in various pharmaceutical formulations. The method had a high degree of specificity and was suitable for speciation analysis of these polymers. So far the developed method has not been used in the control of medicinal products containing dimeticone or simeticone.
制药行业是聚二甲基硅氧烷(PDMS)的重要应用领域之一,PDMS 属于有机硅聚合物。在内部用药物中,它们被用作一种名为二甲硅油或硅酮的活性药物成分(API)。由于其特殊的化学性质,PDMS 可以具有不同程度的聚合,这决定了分子量和粘度。二甲硅油和硅酮的《药典》专论仅给出了允许的聚合度和粘度范围。然而,了解药物制剂中存在的 PDMS 的聚合度或特定分子量也是至关重要的。文献中有关于粒径(即分子量)对生物体毒性、吸收和迁移的影响的信息。本研究专注于使用一种已开发的方法——排阻色谱法与蒸发光散射检测器(SEC-ELSD)——来识别和测定各种药物制剂中的二甲硅油和硅酮。该方法具有高度的特异性,适用于这些聚合物的形态分析。到目前为止,该方法尚未用于控制含有二甲硅油或硅酮的药物。